Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-02

Clinical Trial Update: Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

View source ↗

Summary

A completed clinical trial evaluated sacral neuromodulation and its impact on urine markers in patients with interstitial cystitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacral neuromodulation (sacral nerve stimulator)

Snippet

Sponsor: Kenneth Peters, MD | Conditions: Interstitial Cystitis | Status: COMPLETED